Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy

BACKGROUND: There are limited data regarding the impact of body mass index (BMI) on outcomes in advanced breast cancer, especially in patients treated with endocrine therapy (ET) + cyclin-dependent kinase 4/6 inhibitors. METHODS: A pooled analysis of individual patient-level data from MONARCH 2 and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Natl Cancer Inst
Main Authors: Franzoi, Maria Alice, Eiger, Daniel, Ameye, Lieveke, Ponde, Noam, Caparica, Rafael, De Angelis, Claudia, Brandão, Mariana, Desmedt, Christine, Di Cosimo, Serena, Kotecki, Nuria, Lambertini, Matteo, Awada, Ahmad, Piccart, Martine, de Azambuja, Evandro
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8023855/
https://ncbi.nlm.nih.gov/pubmed/32750143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djaa116
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados